Sökning: L773:1472 9792 OR L773:1873 281X
> (2020-2024) >
A high content scre...
A high content screening assay for discovery of antimycobacterial compounds based on primary human macrophages infected with virulent Mycobacterium tuberculosis
-
- Kalsum, Sadaf (författare)
- Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten,Karolinska Inst, Sweden
-
- Otrocka, Magdalena (författare)
- Karolinska Inst, Sweden; Polish Acad Sci, Poland
-
- Andersson, Blanka (författare)
- Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten
-
visa fler...
-
- Welin, Amanda (författare)
- Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten
-
- Schön, Thomas (författare)
- Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten,Region Östergötland, Infektionskliniken i Östergötland,Kalmar Cty Hosp, Sweden
-
- Jenmalm-Jensen, Annika (författare)
- Karolinska Institutet
-
- Lundback, Thomas (författare)
- Karolinska Inst, Sweden; AstraZeneca, Sweden
-
- Lerm, Maria (författare)
- Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten
-
visa färre...
-
(creator_code:org_t)
- CHURCHILL LIVINGSTONE, 2022
- 2022
- Engelska.
-
Ingår i: Tuberculosis. - : CHURCHILL LIVINGSTONE. - 1472-9792 .- 1873-281X. ; 135
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Drug resistance in Mycobacterium tuberculosis is an emerging threat that makes the discovery of new candidate drugs a priority. In particular, drugs with high sterilizing activity within host cells are needed to improve efficacy and reduce treatment duration. We aimed to develope and validate a High Content Screening assay based on Mycobacterium tuberculosis-infected primary human monocyte-derived macrophages as its natural reservoir. Infected primary human monocyte-derived macrophages were exposed to control antibiotics or tested compounds on 384 well plates. Intracellular bacterial growth and macrophage numbers were evaluated using an ImageXpress High Content Screening system and Z-factor was calculated to assess the reproducibility. The combination of isoniazid and rifampicin as a positive control rendered a Z-factor above 0.4, demonstrating suitability of the assay for screening and compound profiling purposes. In a validation experiment, isoniazid, rifampicin, moxifloxacin and levofloxacin all effectively inhibited intracellular growth as expected. Finally, a pilot screening campaign including 5700 compounds from diverse libraries resulted in the identification of three compounds with confirmed antimycobacterial activity in the low micromolar range and low host cell toxicity. The assay represents an attractive screening platform for both academic research on host-pathogen mechanisms in tuberculosis and for the identification and characterization of novel antimycobacterial compounds.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Microbiology in the medical area (hsv//eng)
Nyckelord
- Mycobacterium tuberculosis; Primary human monocyte-derived macro-phages; Phenotypic assay; High content screening
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas